Literature DB >> 8105164

Insulin resistance in insulin-dependent diabetic patients with microalbuminuria.

J Yip1, M B Mattock, A Morocutti, M Sethi, R Trevisan, G Viberti.   

Abstract

In insulin-dependent diabetes, microalbuminuria increases the risk of cardiovascular and renal disease. By means of a euglycaemic hyperinsulinaemic clamp method, we measured total-body glucose utilisation rate and studied the interaction of this measure of insulin sensitivity with known risk factors for cardiovascular disease in 14 diabetic patients with microalbuminuria and 14 with normal albumin excretion (median albumin excretion rate [AER] 56.2 [range 39.2-80.6] vs 8.8 [7.4-10.7] micrograms per min). The two groups were of similar age, duration of diabetes, and body-mass index. Total-body glucose disposal rate was significantly lower in the patients with microalbuminuria than in those without (mean 7.86 [SD 1.40] vs 9.04 [0.90] mg/kg per min; p < 0.05). There were also significant differences between the groups in the daily insulin dose needed for equivalent glucose control (0.76 [0.20] vs 0.65 [0.10] U/kg, p < 0.05), mean systolic blood pressure over 24 h ambulatory monitoring (134 [7] vs 127 [7] mm Hg; p < 0.05), and various plasma lipid concentrations, contributing to a more atherogenic profile in the microalbuminuric group. Total-body glucose disposal rate was inversely correlated with body-mass index and log10 AER. The insulin sensitivity of the microalbuminuric group remained impaired after adjustment for blood pressure and body-mass index. Impaired insulin sensitivity is a feature of insulin-dependent diabetic patients with microalbuminuria, which adds, with other factors, to the increased risks of renal and cardiovascular disease in these patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8105164     DOI: 10.1016/0140-6736(93)91943-g

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  46 in total

1.  Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005.

Authors:  P Rossing
Journal:  Diabetologia       Date:  2005-12-09       Impact factor: 10.122

2.  Nonalcoholic fatty liver disease markers are associated with insulin resistance in type 1 diabetes.

Authors:  Tomislav Bulum; Branko Kolarić; Lea Duvnjak; Marko Duvnjak
Journal:  Dig Dis Sci       Date:  2011-07-07       Impact factor: 3.199

Review 3.  Lipid biology of the podocyte--new perspectives offer new opportunities.

Authors:  Alessia Fornoni; Sandra Merscher; Jeffrey B Kopp
Journal:  Nat Rev Nephrol       Date:  2014-05-27       Impact factor: 28.314

4.  P38 mitogen-activated protein kinase mediates hexosamine-induced TGFbeta1 mRNA expression in human mesangial cells.

Authors:  D J Burt; G Gruden; S M Thomas; P Tutt; C Dell'Anna; G C Viberti; L Gnudi
Journal:  Diabetologia       Date:  2003-04-05       Impact factor: 10.122

5.  Insulin sensitivity modifies the relationship between thyroid function and lipid profile in euthyroid type 1 diabetic patients.

Authors:  Tomislav Bulum; Branko Kolarić; Lea Duvnjak
Journal:  Endocrine       Date:  2012-01-15       Impact factor: 3.633

6.  In situ protein Kinase C activity is increased in cultured fibroblasts from Type 1 diabetic patients with nephropathy.

Authors:  E Iori; M C Marescotti; M Vedovato; G Ceolotto; A Avogaro; A Tiengo; S Del Prato; R Trevisan
Journal:  Diabetologia       Date:  2003-03-26       Impact factor: 10.122

7.  Prevalence and risk factors for diabetic retinopathy among Omani diabetics.

Authors:  O A el Haddad; M K Saad
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638

8.  Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM.

Authors:  C M Forsblom; J G Eriksson; A V Ekstrand; A M Teppo; M R Taskinen; L C Groop
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

Review 9.  Insulin resistance in type 1 diabetes: what is 'double diabetes' and what are the risks?

Authors:  S J Cleland; B M Fisher; H M Colhoun; N Sattar; J R Petrie
Journal:  Diabetologia       Date:  2013-04-24       Impact factor: 10.122

10.  Functional annotations of diabetes nephropathy susceptibility loci through analysis of genome-wide renal gene expression in rat models of diabetes mellitus.

Authors:  Yaomin Hu; Pamela J Kaisaki; Karène Argoud; Steven P Wilder; Karin J Wallace; Peng Y Woon; Christine Blancher; Lise Tarnow; Per-Henrik Groop; Samy Hadjadj; Michel Marre; Hans-Henrik Parving; Martin Farrall; Roger D Cox; Mark Lathrop; Nathalie Vionnet; Marie-Thérèse Bihoreau; Dominique Gauguier
Journal:  BMC Med Genomics       Date:  2009-07-09       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.